The Form 4 filing, an SEC report of an insider's stock transactions, was filed on November 17, 2026. It lists a November 16 sale by Brian G. Lloyd, Merit Medical Systems' chief legal officer and secretary.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 16,722 |
| Price | $86.33 |
| Total Transaction Value | $1,443,526.65 |
| Insider | |
| Ticker Symbol | MMSI |
| Company | MERIT MEDICAL SYSTEMS INC |
| Insider Name | Lloyd Brian G. |
| Insider Title | CHIEF LEGAL OFFICER, SECRETARY |
| Sector - Industry | Healthcare - Medical Instruments & Supplies |
| Holdings | |
| Total Shares Owned After Transaction | 60,132 |
| Position Size Change | 21.76% |
| Filing | |
| Filing Date | 2026-11-17 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale under transaction code S. The details also suggest a link to an exercise or conversion. That step can turn certain stock rights or other holdings into shares.
What was the average price of the transaction?
The average sale price was $86.325 per share. Rounded to cents, that is $86.33, as shown in the table.
How did this transaction affect the insider's holdings?
Brian G. Lloyd sold 16,722 shares and reported 60,132 shares owned afterward. The sale covered 21.76% of the reported shares held before the sale.
What's the total transaction value?
The reported total value was $1,443,526.65 for the one sale. This is the full sale value, while $86.325 is the average price for each share.
Are there any special circumstances around this transaction?
Yes. The available details include a Rule 10b5-1 reference. These trading plans set instructions in advance. The details do not show when the plan was set up or whether it covered this sale.
The sale is also linked to a code M exercise or conversion involving the same number of shares. The related acquisition details and filing footnotes are unavailable. Matching share counts alone do not confirm that both steps involved the same dates, share types or accounts. They also do not confirm that the exact shares received were sold.
For research purposes only; not investment advice.